Roberto A. Mignone's Insider Trades & SAST Disclosures

Roberto A. Mignone's most recent trade in Guardant Health Inc was a trade of 6,833 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Guardant Health Inc
Roberto A. Mignone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 6,833 6,833 - - Stock Option (Right to Buy)
Guardant Health Inc
Roberto A. Mignone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 4,203 4,203 - - Restricted Stock Units
Teva- Pharmaceutical Indus...
Roberto A. Mignone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2025 14,492 14,492 - - Restricted Share Units
Teva- Pharmaceutical Indus...
Roberto A. Mignone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2025 9,632 105,315 (0%) 0% - Ordinary Shares
Teva- Pharmaceutical Indus...
Roberto A. Mignone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2025 9,632 0 - - Restricted Share Units
Teva- Pharmaceutical Indus...
A. Roberto Mignone Director Sale of securities on an exchange or to another person at price $ 22.01 per share. 20 Dec 2024 286,000 695,000 (0%) 0% 22.0 6,294,031 Ordinary Shares
Guardant Health Inc
Roberto A. Mignone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2024 19,535 19,535 - - Stock Option (Right to Buy)
Guardant Health Inc
Roberto A. Mignone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2024 12,671 12,671 - - Restricted Stock Units
Teva- Pharmaceutical Indus...
Roberto A. Mignone Director Sale of securities on an exchange or to another person at price $ 17.03 per share. 18 Jun 2024 519,000 981,000 (0%) 0% 17.0 8,838,570 Ordinary Shares
Teva- Pharmaceutical Indus...
Roberto A. Mignone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2024 21,108 0 - - Restricted Share Units
Teva- Pharmaceutical Indus...
Roberto A. Mignone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2024 21,108 1,595,683 (0%) 0% - Ordinary Shares
Teva- Pharmaceutical Indus...
Roberto A. Mignone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 9,632 9,632 - - Restricted Share Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades